
On November 3, I joined "Built to Last: Insurance, Liquidity and the Long-Term Cross-Border Portfolio" at Uncorrelated Cayman. Thank you to Antonio J. Lopez of Access Global and Jimmy Milliron of National Brokerage Atlantic for having me on the panel.
The session was built around a hard question. Many funds sold to international investors are being marked down, extended or rolled into continuation vehicles. Who will still be accountable in five years?
01 · Life insurance. Jimmy covered this side: private placement life insurance and how premium-financed policies are structured. One approach I'd add: F9 issues a lender-approved letter of credit, the client's fee is wrapped into the financing, and the pledged collateral can be released.
02 · Commercial insurance. On stage, I spoke from my own commercial experience: D&O, E&O, GPL ("general partnership liability"), and reps and warranties.
"Everybody's curious how the big firms do it, and insurance is at the center of a lot of that decision-making. There's value in really understanding how your management liability program works: your D&O, E&O, fiduciary, crime, cyber and GPL coverage. How it protects you, and how consequential that can be when you're running a fund or you're an independent advisor."
Seat by seat:
Fund managers. GPL is built to defend the GP, the adviser and its people when LPs or regulators question valuation, fees or conflicts. Fines, penalties and returned fees are often outside it. It's the core policy for a manager.
Sponsors. Reps and warranties insurance is built to cover losses from a seller's breach the buyer didn't know about, above a retention. The seller can exit with limited recourse, usually fraud and excluded matters. The buyer can bid without a big escrow. It doesn't cover what's already known, and it won't fix a weak process.
External advisors. Fund administrators, valuation agents and other service providers are exposed to NAV and valuation errors. E&O answers the claim that the work was wrong. If you sit on a fund or portfolio board, D&O answers the claim about how you governed. Ask who covers you in that seat.
Capital allocators. You don't buy these policies, but you inherit them. When a fund indemnifies its GP, LP money can end up paying for the defense. GPL can be structured to respond ahead of, or reimburse, that indemnity. Ask whether LP claims are covered or blocked by insured-vs-insured wording.
Placement firms. Firms like Antonio's Access Global put their name between a manager and an investor, often across borders. The coverage behind each manager they bring to market is part of the diligence.
Coverage depends on the issued policy and loss facts.
In October, ILPA released its final continuation-vehicle guidance, which gives reps and warranties insurance a clear role in GP-led deals and says plainly it cannot replace fair pricing or a fair process. Insurers keep leaning into private markets: BlackRock's insurer survey, published in late October, found more than three in four plan to raise those allocations.
Why it matters for cross-border capital: these claims show up in a workout, an extension or at exit, years after the money moved. Insurance doesn't fix a bad deal. It's built to keep a good one from being undone by a claim nobody saw coming.
A big thank-you to Geoff Marcus and the Uncorrelated Alts team for organizing Uncorrelated Cayman at Hotel Indigo Grand Cayman.
General information only, not legal, tax or insurance advice.